Life-science briefing: Wednesday, March 12, 2008
TODAY’S HEADLINES:
- EyeGate Pharma takes in $15M for eye-drug delivery (release)
- Pronostics raises £3M for autoimmune diagnostics (VentureWire)
- TPG Biotech funds development of Japanese growth hormone, EPO (release)
- Immucor acquires gene- and protein-chip maker BioArray for $117M (release)
- Phase Bioscience gets $1M loan for protein purification (release)
Next Story: Next New Networks raises $15M more for video channels
Previous Story: Roundup: File-sharing Pando gets funding, FCC may go after Comcast, Disney expects $1B from online
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
VB Writers
Ben PopperEast Coast Editor
Dean TakahashiLead Writer, GamesBeat
Devindra HardawarNational Editor, MobileBeat Lead
Dylan TweneyExecutive Editor
ShoeEditor-in-Chief, GamesBeat
Heather KellySenior Editor
Jennifer Van GroveWriter
Jolie O'DellWriter
Matt MarshallFounder & Editor-in-Chief
Meghan KellyWriter
Sarah MitroffEditorial Assistant
Sean LudwigWriter
Sebastian HaleyReviews Editor, GamesBeat
Tom CheredarWriter
Ciara ByrneContributor
Julia PlevinContributor
Lindsey ComptonContributor
